Amberstone Biosciences
PrivateLast Round
Series A
Jan 3, 2022
Total Funding Raised
$12.23M
Company Overview
Amberstone Biosciences is a biotechnology company developing a novel class of targeted and conditionally active immunotherapeutics to treat solid tumor cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Amberstone Biosciences Comparables
Compare Amberstone Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Bonum Therapeutics | 89% | |
| Tentarix Biotherapeutics | 82% | |
| Werewolf Therapeutics | 77% | |
Amberstone Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 3, 2022 | ||||
| Grant | Aug 29, 2019 |
Key People
Founding team and executive leadership
Amberstone Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Co-Win Ventures | Series A |
| Viva BioInnovator | Series A |
| Sinovation Ventures | Series A |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 19, 2026
Monthly visitors grew 461% MoM, from 285 to 1.6K.
- Nov 7, 2025
Monthly visitors grew 61% MoM, from 664 to 1.1K.
Amberstone Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Amberstone Biosciences's valuation, stock price, and market status.